Dexamethasone Sodium Phosphate Injection, Solution
Product Images NDC 71872-7347

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dexamethasone Sodium Phosphate (NDC 71872-7347). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7347.pdp (7347)

This text provides information about Dexamethasone Sodium Phosphate Injection USP, including dosage, administration, composition, storage instructions, and manufacturer details. The injection is intended for intravenous, intramuscular, infraarticular, soft tissue, or intralesional use. The formulation is sterile, nonpyrogenic, and the container closure does not contain natural rubber latex. The dosage is specified in the package insert. It should be stored at 20° to 25°C and protected from light until use. The manufacturer is NDG located in India.*

FDA Label Image

7347m.pdp (7347m)

This text appears to be a prescription label for a medication called Dexamethasone Sodium Phosphate Injection. The medication is used for intravenous or intramuscular administration. It provides information about the manufacturer, SAGENT Pharmaceuticals, from Schaumburg, IL, USA, with the product being made in India. The code number on the label is TS/DRUGS/2/2015. Remember to consult a healthcare professional for proper usage and dosage guidance.*

FDA Label Image

Figure (Dex1z 0000 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.